Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cohn

Showing results (181-190 of 410) with videos related to

Pageof 41
Sort By:
Journal of Cardiac Failure|July 25, 2000
What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?J M Nicklas, J N Cohn, B Pitt
Clinical Pharmacology and Therapeutics|May 1, 1973
Positive inotropic effect of oral esproquin in normal subjectsB Kotelanski, R J Grozmann, J N Cohn
The American Journal of Cardiology|December 1, 1989
Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failureS R Goldsmith, G Francis, J N Cohn
American Heart Journal|July 1, 1983
The effects of bromocriptine in patients with congestive heart failureG S Francis, R Parks, J N Cohn
Circulation|October 1, 1977
Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failureE Mikulic, J N Cohn, J A Franciosa
Gastroenterology|June 1, 1971
Hepatic lobar distribution of splenic and mesenteric blood flow in manR J Groszmann, B Kotelanski, J N Cohn
Journal of Pediatric Ophthalmology and Strabismus|November 1, 1987
Bradycardia with traumatic hyphema in childrenJ N Cohn, D Scagliotti, T A Deutsch
British Journal of Clinical Pharmacology|June 1, 1982
A review of the haemodynamic effects of labetalol in manJ N Cohn, J Mehta, G S Francis
Circulation|March 1, 1986
Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failureM Petein, T B Levine, J N Cohn
Journal of the American College of Cardiology|August 1, 1984
Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failureM Petein, T B Levine, J N Cohn
Pageof 41

Showing results (181-190 of 410) with videos related to

Sort By:
Pageof 41
Journal of Cardiac Failure|July 25, 2000
What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?J M Nicklas, J N Cohn, B Pitt
Clinical Pharmacology and Therapeutics|May 1, 1973
Positive inotropic effect of oral esproquin in normal subjectsB Kotelanski, R J Grozmann, J N Cohn
The American Journal of Cardiology|December 1, 1989
Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failureS R Goldsmith, G Francis, J N Cohn
American Heart Journal|July 1, 1983
The effects of bromocriptine in patients with congestive heart failureG S Francis, R Parks, J N Cohn
Circulation|October 1, 1977
Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failureE Mikulic, J N Cohn, J A Franciosa
Gastroenterology|June 1, 1971
Hepatic lobar distribution of splenic and mesenteric blood flow in manR J Groszmann, B Kotelanski, J N Cohn
Journal of Pediatric Ophthalmology and Strabismus|November 1, 1987
Bradycardia with traumatic hyphema in childrenJ N Cohn, D Scagliotti, T A Deutsch
British Journal of Clinical Pharmacology|June 1, 1982
A review of the haemodynamic effects of labetalol in manJ N Cohn, J Mehta, G S Francis
Circulation|March 1, 1986
Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failureM Petein, T B Levine, J N Cohn
Journal of the American College of Cardiology|August 1, 1984
Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failureM Petein, T B Levine, J N Cohn
Pageof 41